RedHill Biopharma Ltd.
RDHL· Nasdaq
RedHill Biopharma Ltd.
- Last sale
- Oct 2, 2026 · +5.38%
- Market cap
- $2.52M
- 5.09M shares
- Filings
- 1,016
Price
Oct 2, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2024 | 2024-12-31 | $8,043,000 | reported | |
| FY 2023 | 2023-12-31 | $6,530,000 | reported | |
| FY 2022 | 2022-12-31 | $61,800,000 | reported | |
| FY 2021 | 2021-12-31 | $85,757,000 | reported | |
| FY 2020 | 2020-12-31 | $64,359,000 | reported | |
| FY 2019 | 2019-12-31 | $6,291,000 | reported | |
| FY 2018 | 2018-12-31 | $8,360,000 | reported | |
| FY 2017 | 2017-12-31 | $4,007,000 | reported | |
| FY 2016 | 2016-12-31 | $101,000 | reported | |
| FY 2015 | 2015-12-31 | $3,000 | reported |
RedHill Biopharma Ltd. · CIK 1553846 · Engraved from SEC EDGAR
